MUSCLE TENSION DYSPHONIA

  • Irena Hočevar Boltežar Klinika za otorinolaringologijo in cervikofacialno kirurgijo Klinični center Zaloška 2 1525 Ljubljana
Keywords: voice disorders, functional dysphonia, etiology, diagnostic procedures, treatment

Abstract

Background. Muscle tension dysphonia (MTD) is the cause of hoarseness in almost one half of the patients with voice disorders. The otorhinolaryngologic examination discovers no evident organic lesions in the larynx at least in the beginning of the voice problems. The reason for the hoarse voice is a disordered and maladjusted activity of the muscles taking part in phonation and/or articulation. In some patients, the irregular function of the larynx results in mucosal lesions on vocal folds. The factors participating in the development of MTD, directly or indirectly influence the quality of laryngeal mucosa, the activity of the phonatory muscles and/or increase of the vocal load. In the diagnostics and treatment of the MTD a phoniatrician, a speech and language therapist and a psychologist closely cooperate with the patient who must take an active role. The treatment is a long-lasting one but resulted in a high percentage of clinical success.

Conclusions. Most likely, MTD is not a special disease but only a reflection of any disorder in the complicated system of regulation and realization of phonation. The prognosis of treatment is good when all unfavourable factors participating in development of MTD are eliminated and a proper professional voice- and psychotherapy started.

Downloads

Download data is not yet available.

References

Dejonckere HP, Bradley P, Clemente P et al. A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques. Eur Arch Otorhinolaryngol 2001; 258: 77–82.

Koufman JA, Blalock PD. Classification and approach to patients with functional voice disorders. Ann Otol Rhinol Laryngol 1982; 91: 372–7.

Koufman JA, Isaacson G. The spectrum of vocal dysfunction. Otolaryngol Clin North Am 1991; 24: 985–8.

Mathieson L. Greene and Mathieson’s The voice and its disorders. 6th Ed. London and Philadelphia: Whurr Publishers, 2001: 121–265.

Johns MM. Update on the etiology, diagnosis, and treatment of vocal fold nodules, polyps, and cysts. Curr Opin Otolaryngol Head Neck Surg 2003; 11: 456–61.

Morrison MD, Rammage LA, Gilles MB et al. Muscular tension dysphonia. J Otolaryngol 1983; 12: 302–6.

Morrison MD, Hamish N, Rammage LA. Diagnostic criteria in functional dysphonia. Laryngoscope 1986; 94: 1–8.

Koufman JA, Blalock PD. Functional voice disorders. Otolaryngol Clin North Am 1991; 24: 1059–73.

Morrison MD, Rammage LA, Nichol H, Pullan B, May P, Salked L. The management of voice disorders. San Diego, California: Singular Publishing Group, Inc., 1994.

Roy N, Ford CN, Bless DM. Muscle tension dysphonia and spasmodic dysphonia: the role of manual laryngeal reduction in diagnosis and management. Ann Otol Rhinol Laryngol 1996; 105: 851–6.

Ansuwarangsee T, Morrison M. Extrinsic laryngeal muscular tension in patients with voice disorders. J Voice 2002; 16: 333–43.

Dworkin JP, Meleca RJ, Abkarian GG. Muscle tension dysphonia. Curr Opin Otolaryngol Head Neck Surg 2000; 8: 169–73.

Rosen CA, Murry T. Nomenclature of voice disorders and vocal pathology. Otolaryngol Clin North Am 2000; 33: 1035–45.

Mysack ED. Pathologies of speech systems. Baltimore: The Williams & Wilkins Company, 1976.

Child DR, Johnson TS. Preventable and nonpreventable causes of voice disorders. Semin Speech Lang 1991; 12: 1–12.

Sataloff RT, Spiegel JR. Care of professional voice. Otolaryngol Clin North Am 1991; 24: 1093–124.

Milutinović Z. Inflammatory changes as a risk factor in the development of phononeurosis. Folia Phoniatr 1991; 43: 177–80.

Spiegel JR, Hawkshaw M, Sataloff RT. Dysphonia related to medical therapy. Otolaryngol Clin North Am 2000; 33: 771–84.

Roy N. Ventricular dysphonia following long-term endotracheal intubation: a case study. J Otolaryngol 1994; 23: 189–93.

Morrison MD. Pattern recognition in muscle misuse disorders: how I do it. J Voice 1997; 11: 108–14.

Seifert K. Funktionelle Störungen des kranio-cervikalen Überganges und HNO Symptomatik – eine Standortbestimmung. HNO 1989; 37: 443–8.

Hülse M. Zervicale Dysphonie. Folia Phoniatr 1991; 43: 181–96.

Aronson AE. Clinical voice disorders. An interdisciplinary approach. 3rd Edition. New York: Thieme Inc., 1990: 117–45.

Roy N, Bless DM, Heisey D. Personality and voice disorders: a superfactor trait analysis. J Speech Lang Hear Res 2000; 43: 749–68.

Gerritsma EJ. An investigation into some personality characteristics of patients with psychogenic aphonia and dysphonia. Folia Phoniatr 1991; 43: 13–20.

Friedl W, Friedrich G, Egger J. Personality and coping with stress in patients suffering from functional dysphonia. Folia Phoniatr 1990; 42: 144–9.

Roy N, Bless DM, Heisey D. Personality and voice disorders: a multitraitmultidisorder analysis. J Voice 2000; 14: 521–48.

Roy N, McGrory JJ, Tasko SM et al. Psychological correlates of functional dysphonia: an evaluation using Minnesota Multiphasic Personality Inventory. J Voice 1997; 11: 443–51.

Roy N, Bless DM. Toward a theory of the dispositional bases of functional dysphonia and vocal nodules: exploring the role of personality and emotional adjustment. In: Kent RD, Ball MJ eds. Voice quality measurement. San Diego: Singular Publishing Group, 2000: 461–80.

Murry T, Rosen CA. Outcome measurements and quality of life in voice disorders. Otolaryngol Clin North Am 2000; 33: 905–16.

Andrade DF, Heuer R, Hockstein NE et al. The frequency of hard glottal attacks in patients with muscle tension dysphonia, unilateral benign masses, and bilateral benign masses. J Voice 1999; 14: 240–6.

Morrison M, Nichol H, Rammage LA. Diagnostic criteria in functional dysphonia. Laryngoscope 1986; 94: 1–7.

Hammond TH, Zhou R, Hammond EH, Pawlak A, Gray SD. The intermediate layer: a morphologic study of the elastin and hyalurinic acid constituents of normal vocal folds. J Voice 1997; 11: 59–66.

Tietze IR. Mechanical stress in phonation. J Voice 1994; 2: 99–105.

Gray SD. Cellular physiology of the vocal folds. Otolaryngol Clin North Am 2000; 33: 679–97.

Gray SD, Pignatari SN, Harding P. Morphologic ultrastructure of anchoring fibers in normal vocal fold basement membrane zone. J Voice 1994; 8: 48–52.

Thibeault SL, Gray SD, Li W et al. Genotypic and phenotypic expression of vocal fold polyps and Reinke’s edema: a preliminary study. Ann Otol Rhinol Laryngol 2002; 111: 302–9.

Bridger MM, Epstein R. Functional voice disorders: a review of 109 patients. J Laryngol Otol 1983; 97: 1145–8.

Schalen L, Andersson K. Differential diagnosis and treatment of psychogenic voice disorder. Clin Otolaryngol 1992; 17: 225–30.

Hočevar-Boltežar I. Vzroki hripavosti – pogled foniatra. In: Čepeljnik J, Globačnik B, Grobler M, Jurček Strmšnik B, Steiner M eds. Zbornik prispevkov 1. kongresa logopedov Slovenije z mednarodno udeležbo. Ljubljana: Zavod za gluhe in naglušne, 2003: 130–4.

Koufman JA. Approach to the patient with a voice disorder. Otolaryngol Clin North Am 1991; 24: 989–98.

Hočevar-Boltežar I, Janko M, Žargi M. Role of surface EMG in diagnostics and treatment of muscle tension dysphonia. Acta Otolaryngol (Stockh) 1998; 118: 739–43.

Morrison MD, Rammage LA. Muscle misuse voice disorders: description and classification. Acta Otolaryngol 1993; 113: 428–34.

Schneider B, Wendler J, Seider W. The relevance of stroboscopy in functional dysphonias. Folia Phoniatr Logop 2002; 54: 44–54.

Prater RJ. Voice therapy. Techniques and applications. Otolaryngol Clin North Am 1991; 24: 1075–92.

Kendall KA, Leonard RJ. Treatment of ventricular dysphonia with botulin toxin. Laryngoscope 1997; 107: 948–53.

Dworkin JP, Meleca RJ, Simpson ML, Garfield I. Use of topical lidocain in the treatment of muscle tension dysphonia. J Voice 2000; 14: 567–74.

Olson-Ramig L, Verdolini K. Treatment efficacy: voice disorders. J Speech Lang Hear Res 1998; 41: 101–16.

MacKenzie K, Millar A, Wilson JA, Sellars C, Deary IJ. Is voice therapy an effective treatment for dysphonia? A randomised controlled trial. Br Med J 2001; 323: 658–61.

Baker J. Psychogenic dysphonia: peeling back the layers. J Voice 1998; 12: 527–35.

How to Cite
1.
Hočevar Boltežar I. MUSCLE TENSION DYSPHONIA. ZdravVestn [Internet]. 1 [cited 26Mar.2019];73(7-8). Available from: https://vestnik.szd.si/index.php/ZdravVest/article/view/2347